BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
213 hedge funds and large institutions have $3.24B invested in Blueprint Medicines in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 98 increasing their positions, 55 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 227 → 213 (-14)
20% less capital invested
Capital invested by funds: $4.06B → $3.24B (-$829M)
25% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 48
Holders
213
Holding in Top 10
4
Calls
$36.3M
Puts
$29.3M
Top Buyers
| 1 | +$56.8M | |
| 2 | +$50M | |
| 3 | +$45.3M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$44.9M |
| 5 |
CC
Casdin Capital
New York
|
+$35.7M |
Top Sellers
| 1 | -$133M | |
| 2 | -$56.5M | |
| 3 | -$43.4M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$34.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.8M |